Testosterone is not a male hormone — it is a human hormone. Women produce testosterone in the ovaries and adrenal glands throughout their lives, and while concentrations are dramatically lower than in men (approximately 15–70 ng/dL in women vs. 300–1,000 ng/dL in men), testosterone serves essential physiological functions in the female body that become increasingly apparent as levels decline with age.
Despite this, testosterone is rarely discussed in the context of women's hormonal health — most hormonal conversations focus on estrogen and progesterone. The result is that a significant proportion of women experiencing symptoms of testosterone deficiency — low libido, fatigue, reduced muscle tone, depressed mood, cognitive fog, and diminished physical performance — never receive accurate assessment or appropriate management.
Testosterone's Roles in Female Physiology
Libido and sexual function: Testosterone is the primary hormonal driver of sexual desire in women. The ovaries and adrenal glands produce testosterone that acts on brain androgen receptors to generate sexual motivation and arousal. Low testosterone is the most common hormonal cause of hypoactive sexual desire disorder (HSDD) in pre- and postmenopausal women — yet it is systematically underaddressed by most gynecologists.
Muscle mass and physical performance: Testosterone stimulates muscle protein synthesis in women as in men — at lower concentrations but through the same androgen receptor-mediated mechanisms. Age-related testosterone decline contributes to the accelerated muscle loss (sarcopenia) of perimenopause and menopause alongside estrogen's decline. Women with higher testosterone levels for their age consistently show better muscle mass preservation, physical performance, and body composition.
Bone density: Testosterone directly stimulates osteoblast activity and bone formation — a contribution to bone mineral density that is independent of estrogen's effects. Women with polycystic ovary syndrome (higher testosterone) show greater bone density than matched controls; women who undergo surgical menopause (abrupt loss of all ovarian hormones including testosterone) show faster bone loss than women in natural menopause.
Mood, motivation, and cognitive function: Testosterone receptors are abundant in the limbic system and prefrontal cortex. Low testosterone in women is associated with depression, reduced motivation, cognitive fog, and a subjective sense of diminished vitality that is distinct from estrogen-related mood changes and responds specifically to testosterone restoration.
Energy metabolism: Testosterone supports mitochondrial function and metabolic rate — contributing to the metabolic slowdown that many women notice in their late 30s and 40s as testosterone begins declining alongside the more widely recognized perimenopausal hormonal shifts.
When Does Testosterone Decline in Women?
Testosterone levels in women begin declining in the mid-20s and fall approximately 50% between the mid-20s and mid-40s. This decline occurs independently of and often precedes the estrogen and progesterone fluctuations of perimenopause — meaning women may experience significant testosterone-related symptoms while still having regular menstrual cycles and "normal" estrogen levels.
Surgical menopause (bilateral oophorectomy) causes the most abrupt and severe testosterone decline — removing the ovaries eliminates approximately 50% of total testosterone production immediately, often producing dramatic sexual, mood, and energy symptoms that are distinct from natural menopause.
Oral contraceptives, particularly combined estrogen-progestin pills, increase sex hormone-binding globulin (SHBG) — a protein that binds testosterone and renders it biologically inactive. Women on oral contraceptives often have reduced free testosterone (the biologically active fraction) despite normal total testosterone levels, which can explain libido and mood effects that are sometimes attributed to other causes.
Recognizing Testosterone Deficiency Symptoms in Women
Symptoms are non-specific but cumulatively suggestive:
- Reduced or absent sexual desire (most specific symptom)
- Persistent fatigue unresponsive to adequate sleep
- Difficulty building or maintaining muscle despite training
- Reduced motivation, drive, and competitive interest
- Depressed mood, particularly "flat" affect
- Cognitive fog, reduced mental sharpness
- Thinning pubic and axillary (armpit) hair
- Reduced bone density on DEXA scanning
Testing Testosterone in Women
Testing is complicated by significant methodological issues. Most standard testosterone assays are calibrated for male reference ranges and lack the sensitivity to precisely measure the much lower female concentrations. Mass spectrometry-based testing (LC-MS/MS) provides far more accurate and sensitive female testosterone measurements than standard immunoassay methods.
What to request: total testosterone (via LC-MS/MS if possible) and free testosterone (or calculated free testosterone from total testosterone + SHBG). Free testosterone reflects bioavailable hormone independent of SHBG binding.
Reference ranges for total testosterone in women: 15–70 ng/dL in premenopausal women; declining to 10–40 ng/dL in postmenopausal women. However, individual symptom threshold varies significantly — some women develop symptoms at 30 ng/dL, others remain asymptomatic at 15 ng/dL.
Lifestyle Approaches to Support Female Testosterone
Resistance training: The most potent modifiable lifestyle determinant of testosterone levels in women. Progressive resistance training — particularly heavy compound movements — acutely elevates testosterone and drives long-term increases in testosterone receptor expression that enhance tissue sensitivity to existing testosterone levels.
Adequate dietary fat: Testosterone is synthesized from cholesterol. Very low-fat diets — particularly those restricting dietary fat below 20% of total energy — are associated with significantly lower testosterone levels in both men and women. Including adequate monounsaturated and saturated fat from whole food sources supports steroidogenesis.
Zinc adequacy: As discussed in the zinc article, zinc is a required cofactor for testosterone biosynthesis. Zinc deficiency directly impairs testosterone production. Women following plant-predominant diets are particularly vulnerable to zinc insufficiency from dietary phytate inhibition.
Sleep adequacy: Testosterone secretion is predominantly nocturnal — inadequate sleep reduces total testosterone output significantly. The sleep-testosterone connection is bidirectional: low testosterone worsens sleep quality, and poor sleep reduces testosterone, creating a cycle that makes both worse.
Stress reduction: Chronically elevated cortisol from psychological or physiological stress suppresses testosterone production through multiple HPA-gonadal axis interactions. Cortisol and testosterone are inversely related — prolonged cortisol elevation is one of the most common reversible causes of low testosterone in otherwise healthy women.
Body composition: Both excessive body fat (which converts testosterone to estrogen via aromatase) and very low body fat (which suppresses ovarian steroidogenesis through hypothalamic energy sensing) impair female testosterone production. Maintaining healthy body composition — not overly lean and not overweight — optimizes the hormonal environment for normal testosterone output.
When to Discuss Medical Options
For women with confirmed low testosterone and significant symptoms impacting quality of life, testosterone therapy — available as low-dose topical gels, creams, or pellets at doses calibrated to female physiology — is an established treatment with meaningful clinical evidence for improving sexual function, mood, energy, muscle mass, and bone density.
Testosterone therapy for women is not universally available — regulatory approval varies by country, and prescribing practices differ significantly. The British Menopause Society and the Endocrine Society both acknowledge testosterone therapy as appropriate for women with HSDD associated with low testosterone after appropriate assessment and counseling.
The Bottom Line
Testosterone is an essential hormone for women's physical vitality, sexual health, mental wellbeing, and long-term metabolic function — and its age-related decline produces a recognizable symptom cluster that deserves clinical acknowledgment rather than dismissal. Lifestyle optimization through resistance training, adequate dietary fat and zinc, quality sleep, and stress management supports testosterone levels within the constraints of aging. For women with confirmed deficiency and significant symptoms, medical evaluation and discussion of appropriate therapy provides an option that can meaningfully restore aspects of vitality that no supplement or lifestyle change alone addresses at moderate-to-severe deficiency levels.
